Fixed Dosing of Liposomal Amphotericin B in Morbidly Obese Individuals
- Resource Type
- Source
- Clinical Infectious Diseases, 70, 2213-2215
Clinical Infectious Diseases, 70(10):ciz885, 2213-2215. Oxford University Press
Clinical Infectious Diseases, 70(10), 2213-2215. Oxford University Press
Clinical Infectious Diseases, 70, 10, pp. 2213-2215 - Subject
Microbiology (medical) medicine.medical_specialty Antifungal Agents optimal dosing Morbidly obese Gastroenterology Fixed dose DEOXYCHOLATE Pharmacokinetics population pharmacokinetics Internal medicine Amphotericin B Medicine Humans AMBISOME In patient Dosing Prospective Studies Prospective cohort study obese business.industry fungal infection fungal treatment PHARMACODYNAMICS Obesity, Morbid Clinical trial lnfectious Diseases and Global Health Radboud Institute for Health Sciences [Radboudumc 4] Infectious Diseases SAFETY Liposomal amphotericin WEIGHT business - Language
- English
- ISSN
- 1058-4838